Dermatology

Study shows favorable results of Solage for treatment of solar lentigines

Published in Drug Week, February 16th, 2007

Solage (mequinol 2%, tretinoin 0.01%) Topical Solution is the only combination product approved in the United States for the treatment of solar lentigines, commonly known as "age spots," that contains two active ingredients, mequinol and tretinoin.

Until recently, most of the therapeutic research for treating solar lentigines has focused on Caucasian patient populations due to the epidemiological data on the disease. While there have been multiple studies demonstrating that the combination of mequinol 2%, tretinoin 0.01% provides clinically significant improvement in Caucasian patients, little research has been done to evaluate its efficacy in ethnic populations or in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2007-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry